Skip to main content
. 2017 May 15;56(10):1169–1173. doi: 10.2169/internalmedicine.56.7927

Table 1.

Patients Background and Laboratory Data on Admission.

Case 1 Case 2
Current Age (year) 19 68
Age at Onset of GD (year) 8 68
Alb g/dL 4.3 4.1
Ca mg/dL 6.7 6.9
P mg/dL 4.8 3.5
Mg mg/dL 1.5 1.5
ALP IU/L 803 360
Cr mg/dL 0.4 0.51
Intact-PTH pg/mL (10-65) 34 7.0
TSH uU/mL (0.35-4.94) <0.001 58.3, <0.03*
FT3 pg/mL (1.71-3.71) 5.85 1.04
FT4 ng/dL (0.70-1.48) 1.29 <0.40, 3.09*
TRAb-2 IU/L (<1.0) N/A 1.7**
TRAb-3 IU/L (<2.0) 2,080 N/A
TSAb % (<120) 1,072 164**
TgAb IU/mL (<28.0) 8 30.2
TPOAb IU/mL (<16.0) 10.2 581.5

Note: underline denotes abnormal values. TSAb: thyroid stimulating antibody TRAb: anti-thyroid-stimulating hormone receptor antibody, TRAb-2: TRAb-second generation assay, TRAb-3: TRAb-third generation assay, TgAb: anti-thyroglobulin antibody, TPOAb: anti-thyroid peroxidase antibody

N/A: not applicable *data measured at onset of GD in another hospital. **measured in euthyroid during L-T4 treatment.